Additionally, in vitro, the USP8 inhibitor-αPD-L1 combination therapy did not significantly improve the killing of tumor cells by activated T cells in Cd274 KO KPC cells compared to parental KPC cells (Fig. S14a, b). This evidence concerns the gene USP8 and neoplasm.